Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.

P Borchmann; A Engert; A Pluetschow; M Fuchs; J Markova; A Lohri; Z Kral; Richard Greil; M Topp; M Villalobos; J Zijlstra; M Soekler; H Stein; HT Eich; RP Mueller; V Diehl

Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.

P Borchmann
, A Engert
, A Pluetschow
, M Fuchs
, J Markova
, A Lohri
, Z Kral
, Richard Greil
, M Topp
, M Villalobos
, J Zijlstra
, M Soekler
, H Stein
, HT Eich
, RP Mueller
, V Diehl

Universitätsklinik für Innere Medizin 3 - Hämatologie, internistische Onkologie, Hämostaseologie, Infektiologie, Rheumatologie und Onkologisches Zentrum

Publikation: Konferenzbeitrag › Poster

Originalsprache	Englisch
Publikationsstatus	Veröffentlicht - 2008
Veranstaltung	50th Annual Meeting of American Society of Hematology (ASH) - San Francisco, California, USA/Vereinigte Staaten Dauer: 6 Dez. 2008 → 9 Dez. 2008

Konferenz mit wissenschaftlichem Inhalt

Konferenz mit wissenschaftlichem Inhalt	50th Annual Meeting of American Society of Hematology (ASH)
Land/Gebiet	USA/Vereinigte Staaten
Ort	San Francisco, California
Zeitraum	6/12/08 → 9/12/08

1 Abstrakt (Zeitschrift)

Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.
Borchmann, P., Engert, A., Pluetschow, A., Fuchs, M., Markova, J., Lohri, A., Kral, Z., Greil, R., Topp, M., Villalobos, M., Zijlstra, J., Soekler, M., Stein, H., Eich, H., Mueller, R. & Diehl, V., 2008, in: BLOOD . 112, 11, S. 367
Publikation: Beitrag in Fachzeitschrift › Abstrakt (Zeitschrift) › Begutachtung

Dieses zitieren

Borchmann, P., Engert, A., Pluetschow, A., Fuchs, M., Markova, J., Lohri, A., Kral, Z., Greil, R., Topp, M., Villalobos, M., Zijlstra, J., Soekler, M., Stein, H., Eich, HT., Mueller, RP., & Diehl, V. (2008). Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.. Postersitzung präsentiert bei 50th Annual Meeting of American Society of Hematology (ASH), San Francisco, California, USA/Vereinigte Staaten.

Borchmann, P ; Engert, A ; Pluetschow, A et al. / Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial. Postersitzung präsentiert bei 50th Annual Meeting of American Society of Hematology (ASH), San Francisco, California, USA/Vereinigte Staaten.

@conference{1fa75146a0cb458189bf738e6e507851,

title = "Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.",

author = "P Borchmann and A Engert and A Pluetschow and M Fuchs and J Markova and A Lohri and Z Kral and Richard Greil and M Topp and M Villalobos and J Zijlstra and M Soekler and H Stein and HT Eich and RP Mueller and V Diehl",

year = "2008",

language = "English",

note = "50th Annual Meeting of American Society of Hematology (ASH) ; Conference date: 06-12-2008 Through 09-12-2008",

}

Borchmann, P, Engert, A, Pluetschow, A, Fuchs, M, Markova, J, Lohri, A, Kral, Z, Greil, R, Topp, M, Villalobos, M, Zijlstra, J, Soekler, M, Stein, H, Eich, HT, Mueller, RP & Diehl, V 2008, 'Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.', 50th Annual Meeting of American Society of Hematology (ASH), San Francisco, California, USA/Vereinigte Staaten, 6/12/08 - 9/12/08.

Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial. / Borchmann, P; Engert, A; Pluetschow, A et al.
2008. Postersitzung präsentiert bei 50th Annual Meeting of American Society of Hematology (ASH), San Francisco, California, USA/Vereinigte Staaten.

Publikation: Konferenzbeitrag › Poster

TY - CONF

T1 - Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.

AU - Borchmann, P

AU - Engert, A

AU - Pluetschow, A

AU - Fuchs, M

AU - Markova, J

AU - Lohri, A

AU - Kral, Z

AU - Greil, Richard

AU - Topp, M

AU - Villalobos, M

AU - Zijlstra, J

AU - Soekler, M

AU - Stein, H

AU - Eich, HT

AU - Mueller, RP

AU - Diehl, V

PY - 2008

Y1 - 2008

M3 - Poster

T2 - 50th Annual Meeting of American Society of Hematology (ASH)

Y2 - 6 December 2008 through 9 December 2008

ER -

Borchmann P, Engert A, Pluetschow A, Fuchs M, Markova J, Lohri A et al.. Dose-intensified combined modality treatment with 2 cycles of BEACOPP escalated followed by 2 cycles of ABVD and involved field radiotherapy (IF-RT) is superior to 4 cycles of ABVD and IFRT in patients with early unfavourable Hodgkin lymphoma (HL): an analysis of the German Hodgkin Study Group (GHSG) HD14 trial.. 2008. Postersitzung präsentiert bei 50th Annual Meeting of American Society of Hematology (ASH), San Francisco, California, USA/Vereinigte Staaten.

Konferenz mit wissenschaftlichem Inhalt

Publikationen

Dieses zitieren